Correlation Between Vericel Corp and OKYO Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vericel Corp and OKYO Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vericel Corp and OKYO Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vericel Corp Ord and OKYO Pharma Ltd, you can compare the effects of market volatilities on Vericel Corp and OKYO Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vericel Corp with a short position of OKYO Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vericel Corp and OKYO Pharma.

Diversification Opportunities for Vericel Corp and OKYO Pharma

-0.53
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Vericel and OKYO is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Vericel Corp Ord and OKYO Pharma Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OKYO Pharma and Vericel Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vericel Corp Ord are associated (or correlated) with OKYO Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OKYO Pharma has no effect on the direction of Vericel Corp i.e., Vericel Corp and OKYO Pharma go up and down completely randomly.

Pair Corralation between Vericel Corp and OKYO Pharma

Given the investment horizon of 90 days Vericel Corp Ord is expected to generate 0.37 times more return on investment than OKYO Pharma. However, Vericel Corp Ord is 2.69 times less risky than OKYO Pharma. It trades about 0.07 of its potential returns per unit of risk. OKYO Pharma Ltd is currently generating about 0.01 per unit of risk. If you would invest  2,930  in Vericel Corp Ord on November 2, 2024 and sell it today you would earn a total of  2,995  from holding Vericel Corp Ord or generate 102.22% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Vericel Corp Ord  vs.  OKYO Pharma Ltd

 Performance 
       Timeline  
Vericel Corp Ord 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Vericel Corp Ord are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating technical and fundamental indicators, Vericel Corp disclosed solid returns over the last few months and may actually be approaching a breakup point.
OKYO Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days OKYO Pharma Ltd has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, OKYO Pharma is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Vericel Corp and OKYO Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vericel Corp and OKYO Pharma

The main advantage of trading using opposite Vericel Corp and OKYO Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vericel Corp position performs unexpectedly, OKYO Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OKYO Pharma will offset losses from the drop in OKYO Pharma's long position.
The idea behind Vericel Corp Ord and OKYO Pharma Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon